MOBT Alleviates Pulmonary Fibrosis through an lncITPF–hnRNP-l-Complex-Mediated Signaling Pathway

Pulmonary fibrosis is characterized by the destruction of alveolar architecture and the irreversible scarring of lung parenchyma, with few therapeutic options and effective therapeutic drugs. Here, we demonstrate the anti-pulmonary fibrosis of 3-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-7-yl(αS)-α,3,4...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Pan, Zhang, Haitong, Li, Huangting, Liu, Bo, Li, Rongrong, Zhang, Jinjin, Song, Xiaodong, Lv, Changjun, Li, Hongbo, Chen, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414852/
https://www.ncbi.nlm.nih.gov/pubmed/36014574
http://dx.doi.org/10.3390/molecules27165336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414852/
https://www.ncbi.nlm.nih.gov/pubmed/36014574
http://dx.doi.org/10.3390/molecules27165336

Ejemplares similares